Ertiprotafib
Ertiprotafib Uses, Dosage, Side Effects, Food Interaction and all others data.
Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improved glycemic excursion during an oral glucose tolerance test.
Trade Name | Ertiprotafib |
Generic | Ertiprotafib |
Ertiprotafib Other Names | Ertiprotafib |
Type | |
Formula | C31H27BrO3S |
Weight | Average: 559.52 Monoisotopic: 558.086429 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in diabetes mellitus type 2.
How Ertiprotafib works
The complete mechanism of action for ertiprotafib and related compounds in vivo may involve multiple independent mechanisms, including (but not necessarily limited to) PTP1b inhibition and dual PPARalpha/PPARgamma agonism.
Innovators Monograph
You find simplified version here Ertiprotafib